Expert Comparison: Your Prescription Weight Loss Options
Wegovy Better Than Mounjaro: Understanding Your Prescription Weight Loss Options
When evaluating whether Wegovy is better than Mounjaro for your weight loss journey, the answer depends on your individual circumstances, medical history, and practical preferences. Both are prescription-only medicines that represent significant advances in weight management, but they work through different biological pathways. Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro (tirzepatide) is a dual-action treatment targeting both GIP and GLP-1 receptors.
The decision between these treatments should always be made with professional clinical guidance, as both require careful medical assessment and ongoing monitoring. At EverydayMeds, our GPhC-registered pharmacy (#9012878) provides both options with comprehensive prescriber support, ensuring you receive the most appropriate treatment for your specific needs. Your prescriber will consider factors including your BMI, weight-related health conditions, previous treatment responses, and lifestyle factors when determining which medication may be more suitable for your weight loss goals.
Wegovy vs Mounjaro Pricing: Transparent UK Treatment Costs
Understanding the cost implications of your weight loss treatment is essential for long-term commitment to your health goals. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance dose of 2.4mg (£209.99). Our bundles provide convenient multi-month supplies, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99.
New customers benefit from discount code FIRST40, whilst returning customers can use DOSE25, both applied at checkout to reach these final prices. Mounjaro follows a similar pricing structure with its own dose escalation schedule, and both treatments are available through the same streamlined ordering process. The key consideration isn't necessarily which treatment costs less, but which provides better value for your specific weight loss needs when prescribed by our qualified clinical team.
Clinical Evidence: Wegovy Better Than Mounjaro Research Considerations
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different populations, with STEP 2 showing ~clinically studied weight loss in patients with type 2 diabetes, and STEP 3 achieving ~16% with intensive behavioural therapy. The recent SELECT trial also demonstrated a 20% reduction in major cardiovascular events, highlighting potential health benefits beyond weight management.
Mounjaro's SURMOUNT trials have shown impressive results through its dual-receptor mechanism, though direct head-to-head comparisons between the treatments require careful interpretation due to different trial designs and patient populations. Both medications have demonstrated significant efficacy when used alongside reduced-calorie diets and increased physical activity, with the choice between them depending on individual patient factors rather than blanket superiority of one over the other.
How Wegovy Works: The GLP-1 Mechanism for Weight Loss
Wegovy functions as a GLP-1 receptor agonist, essentially mimicking a hormone your body naturally produces to regulate appetite and food intake. When you inject Wegovy once weekly, it activates GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. This mechanism helps you feel satisfied with smaller portions whilst reducing the psychological drive to overeat that many people struggle with during weight loss attempts. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety after meals. Unlike stimulant-based weight loss treatments, Wegovy works with your body's natural regulatory systems rather than artificially speeding up your metabolism.
Ordering Process: From Assessment to Treatment Delivery
Starting your weight loss journey with either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture all relevant medical history and current health status. Once submitted, your assessment is reviewed by our qualified prescribers within 3 working days (or 24 hours with our express service), who evaluate your suitability for treatment and determine the most appropriate medication and starting dose. Upon approval, your medication is dispatched via next-day delivery using our temperature-controlled cold-chain system, ensuring the medication maintains its efficacy from our GPhC-registered pharmacy to your door. You'll receive detailed injection instructions, dose escalation schedules, and access to ongoing clinical support throughout your treatment journey. Our prescribers remain available for follow-up consultations, dose adjustments, and any concerns that may arise during your weight loss programme.
Storage and Practical Considerations: Wegovy's Travel Advantage
One practical advantage when considering whether Wegovy is better than Mounjaro relates to storage flexibility, particularly important for frequent travellers or those with busy lifestyles. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C when not in use, and both use convenient pre-filled FlexTouch pens that make weekly injections straightforward and discrete. The dose escalation schedule is mandatory for both treatments, starting with lower doses to minimise potential side effects before gradually increasing to therapeutic levels. Your prescriber will provide detailed guidance on proper injection technique, site rotation, and what to expect during each phase of dose escalation.
Prescription Weight Loss: Beyond the Wegovy Better Than Mounjaro Debate
The question of whether Wegovy is better than Mounjaro ultimately misses the broader point about prescription weight loss treatment: both represent scientifically-backed approaches that can transform lives when used appropriately. The real consideration should focus on which treatment aligns better with your medical profile, lifestyle requirements, and long-term health objectives. Some patients may respond better to Wegovy's established GLP-1 mechanism, whilst others might benefit more from Mounjaro's dual-receptor approach.
What matters most is accessing expert medical guidance to make this determination safely and effectively. Both medications require commitment to lifestyle changes including reduced-calorie diets and increased physical activity, and both benefit from ongoing medical supervision. At EverydayMeds, we ensure you receive not just the medication, but comprehensive support for your entire weight loss journey, regardless of which treatment proves most suitable for your individual circumstances.
Expert Clinical Support: Making the Right Treatment Choice
Rather than determining whether Wegovy is better than Mounjaro in isolation, our approach focuses on matching you with the treatment most likely to support your specific weight loss goals safely and effectively. Our clinical team, operating under GPhC registration #9012878, brings extensive experience in weight management prescribing and stays current with the latest research developments in both medications. We provide ongoing monitoring, dose adjustments, and support throughout your treatment, ensuring you achieve optimal results whilst minimising potential side effects. Both Wegovy and Mounjaro are available through our streamlined service, with new customers using code FIRST40 and returning customers using DOSE25 at checkout. Begin your weight loss transformation today with our expert clinical assessment at https://everydaymeds.co.uk/collections/wegovy, where professional guidance meets convenient, discreet treatment access.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
